AB

Amber Bio

Pharmaceuticals · San Francisco, California, United States

About

The company is developing a first-of-its-kind rna writing platform capable of editing thousands of diverse mutations across patients with a single product.

Company details may include data from People Data Labs, licensed CC BY 4.0.